Literature DB >> 28910674

The inhibitory activity of HL-7 and HL-10 peptide from scorpion venom (Hemiscorpius lepturus) on angiotensin converting enzyme: Kinetic and docking study.

Zahra Setayesh-Mehr1, Ahmad Asoodeh2.   

Abstract

The hypertension is one of the highest risk factors for stroke, myocardial infarction, vascular disease and chronic kidney disease. Angiotensin converting enzyme (ACE) has an important role in the physiological regulation of cardiovascular system. ACE inhibition is a key purpose for hypertension treatment. In this study, two peptides named HL-7 with the sequence of YLYELAR (MW: 927.07Da) and HL-10 with the sequence of AFPYYGHHLG (MW: 1161.28Da) were identified from scorpion venom of H. lepturus. The inhibitory activity of HL-7 and HL-10 was examined on rabbit ACE. The inhibition mechanisms were assayed by kinetic and docking studies. The IC50 values for ACE inhibition of HL-7 and HL-10 were 9.37µM and 17.22µM, respectively. Lineweaver-Burk plots showed that two peptides inhibited rabbit ACE with competitive manner. The molecular docking conformed experimental results and showed that the two peptides interacted with N-domain and C-domain active sites. Also, docking study revealed that the two peptides can form hydrogen and hydrophobic bonds at their binding sites. Both peptides had higher affinity to N-domain. Our results showed that HL-7 exhibited more strong interactions with amino acids at active site. It seems that HL-10 peptide could occupy more space, thereby inhibiting the substrate entrance to active site.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ACE; Blood pressure; Inhibition; Molecular docking; Scorpion venom peptide

Mesh:

Substances:

Year:  2017        PMID: 28910674     DOI: 10.1016/j.bioorg.2017.09.006

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  2 in total

1.  Evaluation of the in vivo antihypertensive effect and antioxidant activity of HL-7 and HL-10 peptide in mice.

Authors:  Zahra Setayesh-Mehr; Leila Vafadar Ghasemi; Ahmad Asoodeh
Journal:  Mol Biol Rep       Date:  2021-07-21       Impact factor: 2.316

Review 2.  Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors.

Authors:  Julio Caballero
Journal:  Molecules       Date:  2020-01-11       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.